CIDRAP newsletters options
Two years into the pandemic, US cancer screening rates still hadn't recovered to pre-crisis levels, putting millions at risk, new data reveal.
Indicators continue to decline, with the 7-day average for new daily cases down 9.2% from a week ago.
Molecular analysis of stool and rectal swab samples reveal widespread colonization with multidrug-resistant organisms.
The Democratic Republic of the Congo, Yemen, Mozambique, and Madagascar all recorded new cases.
Infections are rare and can be severe or fatal, but so far scientists don't see genetic changes that pose an increased threat to people.
Severe complications included necrotizing (flesh-eating) skin lesions, lung dysfunction sometimes accompanied by nodules, and secondary infections and sepsis.
Data show that use of proton-pump inhibitors increased hospital patients' risk of acquiring multidrug-resistant organisms by nearly 50%.
Two recent papers claim there are no differences between surgical masks and respirators for preventing the spread of respiratory diseases like COVID-19 and flu, but the articles are deeply flawed.
COVID-19 survivors with persistent symptoms are at more than double the risk of new-onset cardiovascular symptoms, suggests a meta-analysis.
US celebrity Twitter posts—especially those from politicians and news anchors—likely influenced the increasingly negative US public attitudes toward efforts to combat COVID-19.
Banning the routine use of medically important antibiotics in food-animal production was tied to a reduction in one type of antibiotic-resistant infection in people.
As proportions of recombinant Omicron subvariants rise, especially XBB.1.5, the WHO urged countries to step up surveillance and sequencing.
South Dakota, Tennessee, and Maine were the only states to score "very easy" or "fairly easy" in readability.
Implementing a multifaceted antibiotic stewardship intervention safely reduced antibiotic prescribing for urinary tract infections in frail older adults.
Data show that the use of doxycycline after sex to prevent sexually transmitted infections may not significantly increase resistance to the antibiotic.
The FDA has granted RSVpreF priority review for use in pregnant women to help protect babies against the virus.
The median time to sustained recovery was 11 days in both the ivermectin and placebo group.
In a randomized trial conducted in five countries, a 2-month drug regimen was found to be non-inferior to the standard 6-month treatment.
The roadmap provides a detailed strategy to develop broadly protective vaccines—suitable for wide use—to tackle future COVID-19 variants and other worrisome coronaviruses.
Nearly half of the newborns (46%) stayed in the same room as their mothers, a practice that rose from 23% in March to June 2020 to 74% in January to March 2021.
